XML 34 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations and Comprehensive Loss (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenue:    
Net product revenue $ 6,770 $ 6,893
Contract revenue 904 88
Total revenue 7,674 6,981
Operating expenses:    
Cost of sales 3,382 4,158
Royalty expense 363 282
Research and development 3,538 3,236
Selling, general and administrative 27,651 14,482
Total operating expenses 34,934 22,158
Loss from operations (27,260) (15,177)
Other income (expense):    
Interest income 6 8
Interest expense (1,886) (1,613)
Fair Value, Option, Changes in Fair Value, Gain (Loss) 8,269 (4,258)
Change in fair value of embedded derivatives (14) (81)
Other income (expense) (47) 66
Total other income (expense) 6,328 (5,878)
Net loss before income taxes (20,932) (21,055)
Provision for income taxes 0 0
Net loss (20,932) (21,055)
Earnings Per Share, Basic, usd per share $ (0.15) $ (0.21)
Earnings Per Share, Diluted, usd per share $ (0.20) $ (0.21)
Weighted average common shares outstanding, basic 139,309 100,809
Weighted average common shares outstanding, diluted 145,323 100,809
Comprehensive loss $ (20,932) $ (21,055)